Medical Management of Primary Hypertension
Authors:
- Lot B. PageLPLot B. Page
- James J. SiddJSJames J. Sidd
- 23 November 1972
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 287 (21) , 1074-1081
Abstract
GuanethidineActionsGuanethidine, like reserpine and methyldopa, exerts its antihypertensive action by interfering with neurotransmission at the adrenergic postganglionic nerve terminals, and thereby decreasing arteriolar vasoconstriction. Guanethidine acts both by preventing the release of norepinephrine from the postganglionic nerve terminals and by depleting norepinephrine stores at these terminals. 180–184 Guanethidine also partially depletes the myocardium of its catecholamine stores.185 Unlike methyldopa, guanethidine does not interfere with the synthesis of norepinephrine or result in the synthesis of a false neurotransmitter.Guanethidine decreases heart rate, stroke volume and cardiac output, probably owing to its sympatholytic action on the heart.145, 185 , 186 The decrease in . . .Keywords
This publication has 69 references indexed in Scilit:
- Antihypertensive Effect of ClonidineArchives of internal medicine (1960), 1971
- Insidious and Prolonged Antagonism of Guanethidine by AmitriptylineJAMA, 1970
- Exercise therapy in hypertensive men1970
- Clinical pharmacology of beta‐receptor‐blocking drugsClinical Pharmacology & Therapeutics, 1969
- Hypotensive action of propranololClinical Pharmacology & Therapeutics, 1966
- Bethanidine Sulfate— A New Antihypertensive AgentJAMA, 1965
- Monoamine Oxidase InhibitorsJAMA, 1964
- Pulmonary Changes Associated with Hexamethonium TherapyArchives of internal medicine (1960), 1959
- MECAMYLAMINE (INVERSINE) IN THE TREATMENT OF HYPERTENSIONJAMA, 1957
- Die afferenten Bahnen des Veratrineffektes in den HerznervenNaunyn-Schmiedeberg's Archives of Pharmacology, 1939